Workshop report: Prevention of postoperative recurrence in Crohn's disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 41, Issue 2, 2005, Pages 145-151

  Markowitz, James ^a,j   Markowitz, Jonathan E ^b   Bousvaros, Athos ^c   Crandall, Wallace ^d   Faubion, William ^e   Kirschner, Barbara S ^f   Perrault, Jean ^g   Rosh, Joel ^h   Winter, Harland ⁱ  

^a North Shore LIJ Health System ^*  (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h MORRISTOWN MEMORIAL HOSPITAL   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j SCHNEIDER CHILDREN'S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; BUDESONIDE; FISH OIL; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; ORNIDAZOLE; PLACEBO; PROBIOTIC AGENT;

CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLON RESECTION; CONFERENCE PAPER; CROHN DISEASE; DRUG MECHANISM; GASTROINTESTINAL DISEASE; HUMAN; PARESTHESIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; RISK FACTOR; TASTE DISORDER;

CHEMOPREVENTION; CHILD; CROHN DISEASE; DISEASE-FREE SURVIVAL; HUMANS; POSTOPERATIVE PERIOD; RECURRENCE; RISK FACTORS; TIME FACTORS;

EID: 23244435538     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000172746.86973.ef     Document Type: Conference Paper

References (49)

1. Faubion WA Jr, Loftus EV Jr, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001;121:255-60.
2. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002;8:244-50.
3. Becker JM. Surgical therapy for ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1999;28:371-90, viii-ix.
4. Chardavoyne R, Flint GW, Pollack S, Wise L. Factors affecting recurrence following resection for Crohn's disease. Dis Colon Rectum 1986;29:495-502.
5. Baldassano RN, Han PD, Jeshion WC, et al. Pediatric Crohn's disease: risk factors for post-operative recurrence. Am J Gastroenterol 2001;96:2169-76.
6. Besnard M, Jaby O, Mougenot JF, et al. Postoperative outcome of Crohn's disease in 30 children. Gut 1998;43:634-8.
7. Kader HA, Raynor SC, Young R, et al. Introduction of 6-mercaptopurine in Crohn's disease patients during the peri-operative period: a preliminary evaluation of recurrence of disease. J Pediatr Gastroenterol Nutr 1997;25:93-7.
8. Griffiths AM. Factors that influence the postoperative recurrence of Crohn's disease in childhood. In: Hadziselimovic F, Herzog B, Burgin-Wolff A, eds. Inflammatory Bowel Disease and Coeliac Disease in Children. Boston: Kluwer Academic Publishers, 1990, 131-6.
9. Griffiths AM, Wesson DE, Shandling B, et al. Factors influencing postoperative recurrence of Crohn's disease in childhood. Gut 1991;32:491-5.
10. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991 May;12:439-47.
11. Hyams JS, Mandel F, Ferry GD, et al. Relationship of common laboratory parameters to the activity of Crohn's disease in children. J Pediatr Gastroenterol Nutr 1992;14:216-22.
12. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterol 1990;99: 956-63.
13. Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn's disease remissions with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterol 2004;127: 723-9.
14. Olaison G, Smedh K, Sjodahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut 1992;33:331-5.
15. Tibble JA, Sigthorsson G, Bridger S, et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000;119:15-22.
16. Arnott ID, Drummond HE, Ghosh S. Gut mucosal secretion of interleukin 1beta and interleukin-8 predicts relapse in clinically inactive Crohn's disease. Dig Dis Sci 2001;46:402-9.
17. D'Inca R, Di Leo V, Corrao G, et al. Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol 1999;94:2956-60.
18. Louis E, Belaiche J, van Kemseke C, et al. A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol 1997;9:939-44.
19. Louis E, Belaiche J, Van Kemseke C, et al. Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse. Dig Dis Sci 1995;40:1750-6.
20. Braegger CP, Nicholls S, Murch SH, et al. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992;339:89-91.
21. Tibble J, Teahon K, Thjodleifsson B, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000;47: 506-13.
22. Bunn SK, Bisset WM, Main MJ, et al. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001;32:171-7.
23. Bunn SK, Bisset WM, Main MJ, et al. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001;33:14-22.
24. De Dombal FT. Results of surgical treatment for Crohn's disease. Br J Surg 1972;59:826-9.
25. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology. 1994;106:643-8.
26. Lautenbach E, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterol 1998;115:259-67.
27. Hashemi M, Novell JR, Lewis AA. Side-to-side stapled anastomosis may delay recurrence in Crohn's disease. Dis Colon Rectum 1998;41:1293-6.
28. Bergamaschi R, Pessaux P, Arnaud JP. Comparison of conventional and laparoscopic ileocolic resection for Crohn's disease. Dis Colon Rectum 2003;46:1129-33.
29. Brignola C, Cottone M, Pera A, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterology 1995;108:345-9.
30. McLeod RS, Wolff BG, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995;109:404-13.
31. Caprilli R, Andreoli A, Capurso L, et al. Oral mesalazine (5-aminosalicylic acid: Asacol) for the prevention of post-operative recurrence of Crohn disease. Gruppo Italiano per lo Studio del Colon e del Retto (CISC). Aliment Pharmacol Ther 1994;8:35-43.
32. Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Study VI. Gastroenterology 2000;118:264-73.
33. Florent C, Cortot A, Quandale P, et al. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol 1996;8:229-33.
34. Camma C, Giunta M, Rosselli M, Cottone M. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterol 1997;113:1465-73.
35. Sutherland LR. Mesalamine for the prevention of postoperative recurrence: is nearly there the same as being there? Gastroenterol 2001;118:436-8.
36. Rutgeerts P, Heile M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995;108:1617-21.
37. Rutgeerts P, Van Assche G, D'Haens G, et al. Ornidazol for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2005;128:856-61.
38. Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterol 2004;127:730-4.
39. Domenech E, Scala L, Bernai I, et al. Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study. Gastroenterol Hepatol 2004;27:563-7.
40. Alves A, Panis Y, Joly F, et al. Could immunosuppressive drugs reduce recurrence rate after second resection for Crohn disease? Inflamm Bowel Dis 2004;10:491-5.
41. Belluzzi A, Brignola C, Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996;334:1557-60.
42. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 2000;45:1462-4.
43. Gupta P, Andrew H, Kirschner BS. Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 2000;31:453-7.
44. Prantera C, Scribano ML, Falasco G, et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 2002;51:405-9.
45. Ewe K, Bouger T, Buhr HJ, et al. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol 1999;11: 277-82.
46. Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology 1999;116:294-300.
47. Colombel JF, Rutgeerts P, Malchow H, et al. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut 2001;49:42-6.
48. Hanauer SB, Feagan BG, Lichtenstein GR, et al. ACCENT I Study Group. Maintenance infliximub for Crohn's disease: the ACCENT I randomized trial. Lancet 2002;359:1541-9.
49. Sandborn WJ, Feagan BG. The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain. Gastroenterol 2004;127:990-3.